Volasertib Enhances Sensitivity to TRAIL in Renal Carcinoma Caki Cells through Downregulation of c-FLIP Expression

Polo-like kinase 1 (PLK1) plays major roles in cell cycle control and DNA damage response. Therefore, PLK1 has been investigated as a target for cancer therapy. Volasertib is the second-in class dihydropteridinone derivate that is a specific PLK1 inhibitor. In this study, we examined that combining...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Mi-Yeon Jeon, Kyoung-jin Min, Seon Min Woo, Seung Un Seo, Shin Kim, Jong-Wook Park, Taeg Kyu Kwon
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI AG 2017-11-01
Reeks:International Journal of Molecular Sciences
Onderwerpen:
volasertib
TRAIL
c-FLIP
caspase
apoptosis
Online toegang:https://www.mdpi.com/1422-0067/18/12/2568
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items